Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis

J Neuroimmunol. 1997 Sep;78(1-2):97-107. doi: 10.1016/s0165-5728(97)00089-1.


The myeloperoxidase enzyme (MPO) is expressed specifically in myeloid cells and catalyzes the formation of hypochlorous acid and other cytotoxic oxidants. We previously reported that two alleles of MPO exist which differ in promoter strength due to a base difference in an Alu-encoded hormone response element. The present study shows that the higher expressing MPO genotype is overrepresented in early onset multiple sclerosis in females, implicating MPO in this demyelinating disease. Contrary to the general conception that macrophages lack MPO, immunohistochemical analysis shows that MPO is present in microglia/macrophages in and around MS lesions as shown by colocalization with major histocompatibility antigens HLA-DR and phagocytized myelin. Also, MPO mRNA sequences are detected in cDNA derived from isolated human adult microglia. This is the first evidence that MPO is present in microglia/macrophages at MS lesions, that MPO gene expression occurs in microglia and that MPO plays a role in MS pathogenesis as shown by the allelic disequilibrium in early onset disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • DNA, Complementary / genetics
  • DNA, Complementary / metabolism
  • Female
  • Genotype
  • Humans
  • Immunohistochemistry
  • Macrophages / metabolism
  • Male
  • Microglia / metabolism
  • Middle Aged
  • Multiple Sclerosis / enzymology*
  • Multiple Sclerosis / pathology
  • Peroxidase / genetics
  • Peroxidase / physiology*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism


  • DNA, Complementary
  • RNA, Messenger
  • Peroxidase